- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Leonard Fromer Reflects on AJMC's ACO Coalition Meeting
One of the most exciting takeaways from the ACO and Emerging Healthcare Delivery Coalition is the concept that stakeholders in many facets of healthcare are coming together to make a success out of the accountable care organization revolution, said moderator Leonard Fromer, MD.
One of the most exciting takeaways from the ACO and Emerging Healthcare Delivery Coalition is the concept that stakeholders in many facets of healthcare are coming together to make a success out of the accountable care organization (ACO) revolution, said Leonard Fromer, MD, executive medical director, group practice forum and assistant clinical professor, Department of Family Medicine, University of California, and moderator of the 2-day event.
During the meeting, different stakeholders brought their perspectives, discussed the solutions they have fashioned, and the highlighted successes they are having. Faculty also spoke about “real movement in achieving better Triple Aim results and scores for the patients that we take care of in the ACO settings.”
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
